From Cancer Scare to Comeback, Abivax Shares Erase a Month of Losses in a Day

Abivax stock jumped 38% after new obefazimod trial data eased the cancer-safety fears that had erased weeks of gains. The post From Cancer Scare to Comeback, Abivax Shares Erase a Month of Losses in a Day appeared first on BeInCrypto.